達瑞電子(300976.SZ):擬以增資及股權收購方式取得維斯德80%股權
格隆匯7月31日丨達瑞電子(300976.SZ)公佈,公司擬以自有資金3,000萬元認購東莞市維斯德新材料技術有限公司(簡稱“標的公司”或“維斯德”)新增註冊資本171.4286萬元,並以自有資金人民幣13,400萬元受讓麥德坤、饒熙怡本次交易前持有的維斯德76.5714%股權。本次交易完成後,公司將持有維斯德80%股權,維斯德將成為公司的控股子公司,納入公司合併報表範圍。
東莞市維斯德新材料技術有限公司成立於2018年6月,是一家集研發、設計、生產、銷售為一體的專業碳纖維產品廠商,產品廣泛應用於手機、智能穿戴、智能硬件等消費電子配件,高端手錶碳纖維結構件等領域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.